Status:
UNKNOWN
Dissecting the Pattern of Nodal Spread in Post-neoadjuvant Pancreatoduodenectomy
Lead Sponsor:
Universita di Verona
Conditions:
Pancreas Cancer
Pancreatic Adenocarcinoma
Eligibility:
All Genders
Brief Summary
There has been long-standing debate about nodal dissection in pancreatoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC), with most studies examining the value of nodal yields, number of m...
Eligibility Criteria
Inclusion
- Post-neoadjuvant pancreatoduodenectomy for localized pancreatic ductal adenocarcinoma.
Exclusion
- Oligometastatic disease
- Upfront pancreatectomy
- Incomplete lymphadenectomy
- Macroscopically incomplete resections
- Rare variants of pancreatic cancer
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
850 Patients enrolled
Trial Details
Trial ID
NCT06135649
Start Date
January 1 2013
End Date
December 1 2024
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unit of Pancreatic Surgery - G.B. Rossi Hospital, University of Verona Hospital Trust
Verona, VR, Italy, 37134